However, such evidence is relatively limited for TM6SF2 where only a couple of studies reported overrepresentation of TM6SF2 rs58542926 risk allele in CHC patients displaying hepatic scarring (fibrosis and cirrhosis) [30, 33]. Here, TM6SF2 is linked to fibrosis.